After adjusting for clinicopathological factors, high STAT5a expression remained significantly associated with favorable survival in breast cancer (lnHR = −0.6091 [−1.0810, −0.1372], P-value = 0.0114). This evidence concerns the gene STAT5A and breast cancer.